<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> is an <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> that is characterised by tendency to <z:mp ids='MP_0005048'>thrombosis</z:mp>, obstetrical and hematological complications </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="50858">Corticosteroids</z:chebi> may be useful for therapy of some features of this syndrome, such as <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Nocardia is an important opportunistic infectious agent in immunocompromised hosts, i.e. in patients taking <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>It is important to be aware of these rare complications, which are correlated with the prognosis </plain></SENT>
<SENT sid="4" pm="."><plain>In this paper, we report a patient with primary anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome treated by <z:chebi fb="0" ids="50858">corticosteroid</z:chebi>, who developed <z:e sem="disease" ids="C0343524" disease_type="Disease or Syndrome" abbrv="">disseminated nocardiosis</z:e> </plain></SENT>
</text></document>